Liposarcoma staging: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Mahshid)
 
(11 intermediate revisions by 3 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
The staging of liposarcoma is based on the TNM classification, which includes primary tumor spread, [[lymph node]] involvement, and presence of [[metastasis]].


==Staging==
==Staging==
{|
| valign=top |
{| style="border: 0px; font-size: 90%; margin: 3px; width: 350px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px; width: 350px;" align=center
|valign=top|
|valign=top|
Line 11: Line 14:
! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Primary Tumor (T)}}
! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Primary Tumor (T)}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: 100px;"  | Tx
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: 50px;"  | Tx
| style="padding: 5px 5px; background: #F5F5F5;; width: 250px;" | Tumor cannot be assessed.
| style="padding: 5px 5px; background: #F5F5F5;; width: 300px;" | Tumor cannot be assessed.
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;"|T0
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;"|T0
Line 39: Line 42:
| style="padding: 5px 5px; background: #F5F5F5;" | Deep tumor
| style="padding: 5px 5px; background: #F5F5F5;" | Deep tumor
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small>
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Retrieved from the National Cancer Institute. Adapted from AJCC: Soft tissue sarcoma. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 291-8. <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small>
|}
|}
 
|
{| style="border: 0px; font-size: 90%; margin: 3px; width: 500px;" align=center
|valign=top|
{| style="border: 0px; font-size: 90%; margin: 3px; width: 350px;" align=center
|valign=top|
|valign=top|
|+
|+
! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Lymph Nodes (N)}}
! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Lymph Nodes (N)}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: 100px;"  |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: 50px;"  |NX
| style="padding: 5px 5px; background: #F5F5F5;; width: 500px;" |  
| style="padding: 5px 5px; background: #F5F5F5;; width: 300px;" | Lymph nodes cannot be assessed.
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |N0
| style="padding: 5px 5px; background: #F5F5F5;" | No regional lymph node involvement.
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |N1
| style="padding: 5px 5px; background: #F5F5F5;" |Regional lymph node involvement.
|-
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Retrieved from the National Cancer Institute. Adapted from AJCC: Soft tissue sarcoma. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 291-8. <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small>
|}
{| style="border: 0px; font-size: 90%; margin: 3px; width: 350px;" align=center
|valign=top|
|+
! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Metastasis (M)}}
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: 50px;" | M0
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #F5F5F5;; width: 300px;" | No distant metastasis
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |M1
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #F5F5F5;" | Distant metastasis
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small>
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Retrieved from the National Cancer Institute. Adapted from AJCC: Soft tissue sarcoma. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 291-8. <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small>
|}
|}
|}


{| style="border: 0px; font-size: 90%; margin: 3px; width: 500px;" align=center
{| style="border: 0px; font-size: 90%; margin: 3px; width: 700px;" align=center
|valign=top|
|valign=top|
|+
|+
! style="background: #4479BA;" colspan=2 | {{fontcolor|#FFF|Metastasis (M)}}
| style="background: #4479BA; font-weight: bold; width: 100px;" | {{fontcolor|#FFF|Stages}}
| style="padding: 5px 5px; background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Primary Tumor (T)}}
| style="padding: 5px 5px; background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Lymph Node (N)}}
| style="padding: 5px 5px; background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Metastasis (M)}}
| style="padding: 5px 5px; background: #4479BA; width: 100px;" | {{fontcolor|#FFF|Histopathological Grading}}
|-
| style="background: #4479BA; font-weight: bold; width: 100px;" | {{fontcolor|#FFF|Stage IA}}
| style="padding: 5px 5px; background: #DCDCDC; width: 100px;" | T1a, T1b
| style="padding: 5px 5px; background: #F5F5F5; width: 100px;" | N0
| style="padding: 5px 5px; background: #DCDCDC; width: 100px;" | M0
| style="padding: 5px 5px; background: #F5F5F5; width: 100px;" | Low grade
|-
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Stage IB}}
| style="padding: 5px 5px; background: #DCDCDC;" | T2a, T2b
| style="padding: 5px 5px; background: #F5F5F5;" | N0
| style="padding: 5px 5px; background: #DCDCDC;" | M0
| style="padding: 5px 5px; background: #F5F5F5;" | Low grade
|-
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF|Stage IIA}}
| style="padding: 5px 5px; background: #DCDCDC;" | T1a, T1b
| style="padding: 5px 5px; background: #F5F5F5;" | N0
| style="padding: 5px 5px; background: #DCDCDC;" | M0
| style="padding: 5px 5px; background: #F5F5F5;" | High grade
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold; width: 100px;" |
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF| Stage IIB}}
| style="padding: 5px 5px; background: #F5F5F5;; width: 500px;" |  
| style="padding: 5px 5px; background: #DCDCDC;" | T2a, T2b
| style="padding: 5px 5px; background: #F5F5F5;" | N0
| style="padding: 5px 5px; background: #DCDCDC;" | M0
| style="padding: 5px 5px; background: #F5F5F5;" | High grade
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF| Stage III}}
| style="padding: 5px 5px; background: #F5F5F5;" |  
| style="padding: 5px 5px; background: #DCDCDC;" | Any T
| style="padding: 5px 5px; background: #F5F5F5;" | N0, N1
| style="padding: 5px 5px; background: #DCDCDC;" | M0
| style="padding: 5px 5px; background: #F5F5F5;" | High grade
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
| style="background: #4479BA; font-weight: bold" | {{fontcolor|#FFF| Stage IV}}
| style="padding: 5px 5px; background: #F5F5F5;" |
| style="padding: 5px 5px; background: #DCDCDC;" | Any T
| style="padding: 5px 5px; background: #F5F5F5;" | Any N
| style="padding: 5px 5px; background: #DCDCDC;" | M1
| style="padding: 5px 5px; background: #F5F5F5;" | Any grade
|-
|-
| style="padding: 5px 5px; background: #F5F5F5;" colspan=2|<small> Table adapted from National Cancer Institute <ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small>
| style="padding: 5px 5px; background: #F5F5F5;" colspan=5|<small> Retrieved from the National Cancer Institute. Adapted from AJCC: Soft tissue sarcoma. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 291-8.<ref name="NCI"> {{cite web| url=http://www.cancer.gov/cancertopics/pdq/treatment/adult-soft-tissue-sarcoma/HealthProfessional/page3#Section_197| title= National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma}} </ref></small>
|}
|}


Line 81: Line 130:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Oncology]]
[[Category:Surgery]]
[[Category:Surgery]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]

Latest revision as of 02:17, 27 November 2017

Liposarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Liposarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Liposarcoma staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Liposarcoma staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Liposarcoma staging

CDC on Liposarcoma staging

Liposarcoma staging in the news

Blogs on Liposarcoma staging

Directions to Hospitals Treating Liposarcoma

Risk calculators and risk factors for Liposarcoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]

Overview

The staging of liposarcoma is based on the TNM classification, which includes primary tumor spread, lymph node involvement, and presence of metastasis.

Staging
Primary Tumor (T)
Tx Tumor cannot be assessed.
T0 No evidence of primary tumor.
T1 Tumor ≤ 5 cm
T1a
 Superficial tumor (not invading the fascia)
T1b
 Deep tumor
T2 Tumor > 5 cm
T2a
 Superficial tumor (not invading the fascia)
T2b
 Deep tumor
Retrieved from the National Cancer Institute. Adapted from AJCC: Soft tissue sarcoma. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 291-8. [1]
Lymph Nodes (N)
NX Lymph nodes cannot be assessed.
N0 No regional lymph node involvement.
N1 Regional lymph node involvement.
Retrieved from the National Cancer Institute. Adapted from AJCC: Soft tissue sarcoma. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 291-8. [1]
Metastasis (M)
M0 No distant metastasis
M1 Distant metastasis
Retrieved from the National Cancer Institute. Adapted from AJCC: Soft tissue sarcoma. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 291-8. [1]
Stages Primary Tumor (T) Lymph Node (N) Metastasis (M) Histopathological Grading
Stage IA T1a, T1b N0 M0 Low grade
Stage IB T2a, T2b N0 M0 Low grade
Stage IIA T1a, T1b N0 M0 High grade
Stage IIB T2a, T2b N0 M0 High grade
Stage III Any T N0, N1 M0 High grade
Stage IV Any T Any N M1 Any grade
Retrieved from the National Cancer Institute. Adapted from AJCC: Soft tissue sarcoma. In: Edge SB, Byrd DR, Compton CC, et al., eds.: AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer, 2010, pp 291-8.[1]

References

  1. ↑ 1.0 1.1 1.2 1.3 "National Cancer Institute - Stage Information for Adult Soft Tissue Sarcoma".


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Liposarcoma_staging&oldid=1394661"